Jesper Boving, Senior Vice President at Novo Nordisk A/S

Jesper Boving

Senior Vice President at Novo Nordisk A/S | Region Zealand, Denmark

Profile last verified June 2026
Pharmaceuticals Verified Profile Region Zealand, Denmark Harvard Business School
Verified

Work Email

***@novonordisk.com

Last verified May 2026

Phone Number

+45*****

Denmark • Mobile

Free account · No credit card · 5 profiles/month

Jesper Boving Socials
Jesper Boving Work Experience

Senior Vice President at Novo Nordisk A/S in July 2026 - July 2026

Vice President at Novo Nordisk A/S in July 1999 - July 2026

Direktør/Senior Vice President at Novo Nordisk A/S in July 2026 - Present

See more See less

Director at Novo Nordisk A/S in July 1994 - July 1999

Jesper Boving Education

Harvard Business School, July 2026

London Business School, July 2026

Harvard Business School, July 2026

See more See less

IMD, July 2026

IMD, July 2026

Copenhagen Business School, B.Sc.Com., July 1989 to July 1991

DTU - Technical University of Denmark, Master of Science (MSc), July 1981 to July 1986

Jesper Boving Skills
Business Strategy Change Management Strategy Pharmaceutical Industry Cross-functional Team Leadership Team Leadership Strategic Planning Biotechnology GMP Organizational Development Life Sciences Business Planning Clinical Development Biopharmaceuticals FDA Validation Drug Development
About Jesper Boving’s Current Company
Novo Nordisk A/S

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Discover more about Novo Nordisk A/S
Jesper Boving’s Colleagues
Tore Veum

Tore Veum

Norway

Global Director Frontline Excellence Rare Diseases, Novo Nordisk

Owner at Veum Consulting
(March 2015 – Present)

Naheel Korfiatis

Naheel Korfiatis

Dubai, United Arab Emirates

PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk

Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)

Karleen Rush

Karleen Rush

Raleigh-Durham-Chapel Hill Area

Medical Science Liaison, Diabetes & Renal

Wine Rep at ONEHOPE Wine
(June 2021 – Present)

Gaetano Gati

Gaetano Gati

Rome, Latium, Italy

Public Affairs Manager presso Novo Nordisk

Public Affairs Manager at Novo Nordisk
(May 2022 – Present)

Diego Bacelic

Diego Bacelic

Toronto, Ontario, Canada

Obesity Market Access | Novo Nordisk Canada

Consultant at Global Market Access Solutions
(May 2026 – May 2026)

Anne Preskou

Anne Preskou

Copenhagen, Capital Region of Denmark, Denmark

Associate Director – Novo Nordisk

Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)

Search similar profiles
Frequently asked questions about Jesper Boving

What is Jesper Boving email address?

Email Jesper Boving at [email protected]. This email is the most updated Jesper Boving's email found in 2026.

What is Jesper Boving phone number?

Jesper Boving phone number is +4530751486.

How to contact Jesper Boving?

To contact Jesper Boving send an email to [email protected]. If you want to call Jesper Boving try calling on +4530751486. (updated on April 30, 2026)

What company does Jesper Boving work for?

Jesper Boving works for Novo Nordisk A/S.

What is Jesper Boving's role at Novo Nordisk A/S?

Jesper Boving is Senior Vice President

What industry does Jesper Boving work in?

Jesper Boving works in the Pharmaceuticals industry.

Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 1.4M users from 76% of Fortune 500 companies

Microsoft Tenstorrent Merck Rackspace WarnerMedia Societe Generale Yelp Google

The most accurate data ever

CCPA Compliant
GDPR Compliant
150M Personal Emails
200M Work Emails
100M Direct Dials
250M Professional Profiles
40M Company Profiles

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free